The stock of OPKO Health Inc. (NASDAQ:OPK) increased by $0.04 on Tuesday to finish at $1.77, up 2.31 percent. The last five days have seen an average of 3,592,420 shares of common stock traded. 13 times new highs were reached in the current year, with a gain of $0.5200. The average number of shares traded over the last 20 days was 3,122,070, while the average volume over the last 50 days totaled 4,174,916.
OPK stock dropped -4.84% since last month. On 08/22/23, the company’s shares reached a one-month low of $1.6700. The stock touched a high of $2.34 on 07/05/23, after rallying from a low of $1.00 in 52 weeks. The price of OPK stock has risen by 41.60% or $0.5200 this year, reaching a new high 13 times. Still, the stock price is down -24.36% from the 52-week high.
Insider Transactions
OPK stock investors should be aware that OPKO Health Inc. (OPK) stock had its last reported insider trading activity 13 days ago on Aug 17. On Aug 17, CEO & Chairman FROST PHILLIP MD ET AL acquired 100,000 shares at $1.76 each. This transaction resulted in the insider spending $175,804. On Aug 14, FROST PHILLIP MD ET AL added 75,000 shares at a price of US$1.75. After the transaction, the insider now owns 200,856,694 shares. CEO & Chairman FROST PHILLIP MD ET AL had earlier bought 100,000 shares on Aug 09 for $1.82 a share. The transaction was completed for $181,752.
Valuation Metrics
Beta for the stock is 1.77. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.59, the price-to-book (PB) ratio of 0.87.
Financial Health
For the three months ended June 29, OPKO Health Inc.’s quick ratio was 1.60, while its current ratio was 1.90, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.15, and the total debt to equity ratio is 0.17. As far as profitability goes, gross margin for the trailing twelve months is 36.10% percent. OPKO Health Inc.’s EBITDA margin for the year ended June 29 was -13.69%, whereas its operating margin stood at -19.20% for the same period. Based on annual data, it had gross profit of $288.22 million and revenue of $1.0 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. OPK’s return on assets (ROA) during the last 12 months has been -9.60%. There was a -8.90% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -13.30%.
Earnings Surprise
According to OPKO Health Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $265.42 million, while revenues fell by -16.75% to $237.58 million. It was predicted that OPKO Health Inc.’s quarterly earnings would be -$0.03, but it ended up being -$0.07, beating the consensus by 57.10%. EBITDA was $33.87 million for the quarter. At the end of OPKO Health Inc.’s most recent quarter ended June 29, its liabilities totaled 623.55 million, while its total debt was $295.67 million. Equity owned by shareholders amounts to $773.06 million.
Technical Picture
Here’s a quick look at OPKO Health Inc.’s (OPK) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 49.02%, suggesting the stock is Neutral, with a 43.09% historical volatility rate.
The stochastic %K and %D were 26.19% and 23.12% respectively, while the average true range (ATR) was 0.0995. Based on the 14-day stochastic reading of 35.71%, the RSI (14) reading is 47.72%. On the 9-day MACD Oscillator, the stock is at 0.0033, and the 14-day reading is at -0.0174.
Analyst Ratings
In its most recent analyst report, Barrington Research raised its rating on OPKO Health Inc. (NASDAQ: OPK) to an Outperform. Prior to this, analysts firm rated the stock as a Mkt perform. Analysts have assigned OPKO Health Inc. (OPK) an Buy rating. OPK is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 6 others recommend it as a buy.
What is OPK’s price target for the next 12 months?
The current consensus forecast for the stock is between $2.00 and $8.50, with a median target price of $4.00. In analyzing these forecasts, the average price target given by analysts for OPKO Health Inc. (OPK) is $4.48.
